Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population

2018 
This study uses Medicare part B billing data to compare trends in the use of filgrastim and its biosimilars among beneficiaries between 2014 and 2016.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    2
    References
    18
    Citations
    NaN
    KQI
    []